Previous studies have shown that the Ron receptor tyrosine kinase is an important regulator of the acute lung inflammatory response induced by intranasal administration of bacterial LPS. Compared to wild-type mice, complete loss of the Ron receptor in all cell types in vivo was associated with increased lung damage as determined by histological analyses and several markers of lung injury including increases in pro-inflammatory cytokines such as TNF-a. Tumor-necrosis factor-a is a multifunctional cytokine secreted by macrophages, which plays a major role in inflammation and is a central mediator of several disease states including rheumatoid arthritis and sepsis. Based on increased TNF-a production observed in the Ron-deficient mice, we hypothesized that Ron receptor function in the inflammatory cell compartment is essential for the regulating lung injury in vivo. To test this hypothesis, we generated myeloid lineage-specific Ron-deficient mice. In this study, we report that loss of Ron signaling selectively in myeloid cells results in increased lung injury following intranasal administration of LPS as measured by increases in TNF-a production, ensuing neutrophil accumulation and increased lung histopathology. These findings corroborate the role of Ron receptor tyrosine kinase as a negative regulator of inflammation and further demonstrate the in vivo significance of Ron signaling selectively in myeloid cells as a major regulator of this response in vivo. These data authenticate Ron as a potential target in innate immunity and TNF-a-mediated pathologies.
Introduction
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) result in a high degree of patient morbidity and mortality making the identification of the key regulatory components involved in these inflammatory disorders highly desirable. Previous studies with animal models of ALI and ARDS have led to the discovery that macrophage activation initiates the inflammatory cascade which is thought to be the central mediator in lung injury. 1 The initial activation cascade is driven by the pro-inflammatory cytokines, which are thought to initiate alterations in adhesion molecules and chemokine production resulting in the activation of immune cells. [2] [3] [4] The inflammatory cascade is marked by an influx of neutrophils, which are thought to be the primary contributors to lung injury. [5] [6] [7] [8] The identification of TNF-a as a pro-inflammatory, host-tissue damaging cytokine has been well established both experimentally in vivo and clinically, as a therapeutic target in human disease. 9, 10 The identification of a regulatory paradigm for TNF-a release following macrophage activation, however, remains only partially understood.
The Ron receptor tyrosine kinase is widely expressed in epithelial cells and has been found in select macrophage populations including alveolar macrophages. [11] [12] [13] [14] [15] The endogenous ligand for Ron is hepatocyte growth factor-like protein (HGFL), which is secreted primarily from hepatocytes into the circulation as an inactive precursor. 16 The active form of HGFL is generated through protease cleavage at sites of tissue injury which can then bind to and initiate ligand-dependent signaling of the Ron receptor. Our previous studies demonstrated that the Ron receptor regulates TNF-a production in mouse models of LPS-induced acute lung injury. 15, 17 These studies demonstrated that both increases in NF-kB activation and TNF-a cytokine levels typically generated following LPS challenge in wild-type mice was enhanced in Ron tyrosine kinase domain-deficient animals and was associated with worsened lung injury. Additionally, we have identified that Ron receptor activation, by its endogenous ligand HGFL, reduces TNF-a production in alveolar macrophages and in macrophage cell lines following challenge with LPS. Together, these data identify Ron as a key regulatory component in ALI which can be modulated by ligand binding. However, the identification of the in vivo celltype specific mechanism by which Ron imparts its regulation of ALI remains unclear. In this report, we focus on the role of Ron specifically in alveolar macrophages and granulocytes, collectively referred to as myeloid cells, in vivo. Through the use of Lysozyme-Cre expressing mice crossed with floxed Ron mice, which yield a conditional deletion of Ron (Ron F/F Cre) in mouse myeloid cells, we examined the in vivo consequences of Ron deletion in the immune compartment of the lung following induction of ALI after LPS challenge. Specifically, our studies show that the loss of Ron receptor tyrosine kinase in myeloid cells is sufficient to recapitulate the phenotype observed in whole body Ron knockout mice and provide the first evidence of a cell-type specific function of Ron in vivo.
Materials and methods

LPS-induced model of acute lung injury
Homozygous floxed Ron mice (Ron F/F ) encoding for the cytoplasmic TK domain were generated as previously described and were backcrossed 10 generations into a C57BL/6 background. 18 Lysozyme-Cre mice from The Jackson Laboratory (Bar Harbor, ME, USA) were in a C57BL/6 background. Lysozyme-Cre expressing mice were crossed with floxed Ron mice to create a conditional deletion of Ron. All experiments were performed using adult male mice between 8-16 wk of age. Mice were age-matched within 2 wk internally in each experiment. All mice were maintained under specific pathogen-free conditions and were treated in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Cincinnati. The LPS model of acute lung injury was established as previously described. 15, 17 Broncho-alveolar lavage fluid collection and analysis Mice were euthanized by intraperitoneal injections of 200 mg/kg body weight Nembutol (pentobarbital hydrochloride; Ovation Pharmaceuticals, Deerfield, IL, USA). Immediately thereafter, a midline neck incision was made and the trachea was cannulated. The lungs were lavaged twice with 0.7 ml sterile phosphate-buffered saline (PBS). The recovered broncho-alveolar lavage (BAL) fluid was centrifuged at 500 g for 5 min at 4 C, and resuspended in 200 ml of sterile PBS. Red blood cells were lysed using red blood cell lysis buffer (Sigma, St Louis, MO, USA) according to the manufacturer's recommendations. Total cell counts were determined by hemacytometer and cytospin preparations stained with Hema 3 (Fisher Healthcare, Houston, TX, USA) and differential cell counts were determined.
Isolation of RNA and quantitative real-time PCR analysis
For quantitative real-time transcript analysis, RNA was extracted from unlavaged whole lung lysates or isolated alveolar monocytes using Trizol (Invitrogen, Carlsbad, CA, USA) reagent as per the manufacturer's instructions. One microgram of total RNA from lung lysates or 0.05 mg of total RNA from primary alveolar cells was reverse transcribed to cDNA using Applied Biosystems high capacity cDNA reverse transcription kit, according to the manufacturer's instructions. Ron and TNF-a were quantified using real-time PCR with the ABI 7300 instrument using 4 ml of cDNA in 25 ml of Power SYBR green master mix (Applied Biosystems, Foster City, CA, USA). The cycling parameters were: 50 C for 2 min, 95 C for 10 min and then 40 cycles of 95 C for 15 s and 60 C for 1 min. This reaction was followed by a dissociation stage to examine probe specificity. The following primers were used to amplify the cDNA: murine Ron (forwardtcccattgcaggtctgtgtaga, reverse-cggaagctgtatcgttgatgtc), murine TNF-a (forward-catcttctcaaaattcgagtgacaa, reverse-tgggagtagacaaggtacaaccc). Gene expression values were normalized to endogenous b-glucuronidase expression (forward-ttgagaactggtataagacgcatcag; reverse-tctggtggtactcctcactgaacatgc) as an internal control as previously described. 19 Relative gene expression results are reported. Real-time analyses were repeated in duplicate with similar results using samples from at least two independent experiments.
Histological analysis
Unlavaged lung tissue samples were inflation fixed with neutral buffered 10% formalin (Sigma-Aldrich, St Louis, MO, USA) at a pressure of 25 cm H 2 O, and immersed in the same fixative overnight, embedded in paraffin, cut into 5 mm sections, and fixed to superfrost plus slides (Fisher Healthcare, Houston, TX, USA). The lung sections were taken from the same lobe in each mouse 6 h following intranasal LPS administration. An examination for gross pathology and inflammation was performed on hematoxylin and eosin (H&E) stained sections. Neutrophil-specific staining was detected using an anti-neutrophil specific rabbit polyclonal antibody, which has been previously shown to cross-react with mouse neutrophils. 20 In brief, endogenous peroxidase was quenched with 0.3% hydrogen peroxide in methanol, followed by non-specific protein blocking with normal goat serum. Tissue sections were incubated with rabbit anti-neutrophil antibody (1 : 100) overnight at 4 C, followed by 1 : 500 dilution of biotinylated goat anti-rabbit IgG secondary antibody and avidin-peroxidase complex (Vector Laboratories) for 60 min. Diaminobenzidine (DAB) solution was used to form a brown precipitate and the sections were counterstained with nuclear fast red. At least four random sections per mouse were counted under high power magnification (Â400) in a blinded manner.
Protein isolation and assays
Unlavaged lungs were lysed in buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1% SDS) containing protease inhibitor (Complete Mini, EDTA-free; Roche Diagnostics, Indianapolis, IN, USA) and 1 mmol/l Na 3 VO 4 . Proteins were separated by SDS-PAGE and transferred to Immobilon-P membranes (Millipore, Billerica, MA, USA). After transfer, the membranes were probed with a rabbit polyclonal anti-pNF-kB (Ser536, Cat #SC-33020) antibody (1 : 500; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), and a rabbit polyclonal anti-NF-kB (p65 subunit) antibody (1 : 2000; Cell Signaling Technology, Cambridge, MA, USA). Specific binding was detected using an antirabbit peroxidase conjugated secondary antibody. Membranes were developed using ECL Plus Western detection reagent (GE Health Care Life Sciences, Piscataway, NJ, USA) and the images were developed on film. Membranes were stripped and reprobed with anti-actin antibody C4 as a loading control.
ELISA measurements
Cell-free BAL fluid TNF-a levels were measured by ELISA according to the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA).
Statistical analysis
Data are expressed as mean AE SE. Statistical significance comparing different experimental groups was determined by the Student's t-test performed in GraphPad Prism v4.03 software (Prigg Meadow, Ashburton, Devon, UK). Differences between groups were accepted as significant when P < 0.05.
Results
Generation of mice with a myeloid-specific conditional loss of the Ron receptor tyrosine kinase
Previous studies have demonstrated that the Ron receptor can regulate TNF-a production in mouse models of LPS-induced acute lung injury. 15, 17 These studies demonstrated enhanced NF-kB activation, TNF-a production and worsened injury in Ron-deficient mice following LPS challenge compared to wild-type mice. 17 We have also recently demonstrated that primary alveolar macrophages from Ron-deficient mice treated with LPS exhibit increased NF-kB activation and TNF-a cytokine levels compared to Ron-sufficient cells. 15 Moreover, we have identified that ligand stimulated (HGFL) Ron receptor activation is sufficient to reduce TNF-a production in alveolar macrophages and in macrophage cell lines following LPS challenge. These studies collectively argue that Ron-dependent macrophage-specific signaling is a major contributor to the development of acute lung injury in vivo. However, cell-type specific Ron receptor function has not yet been evaluated in vivo under any experimental conditions. In order to selectively determine the in vivo role of Ron signaling in the immune compartment of the lung, the loss of Ron in macrophages and neutrophils was achieved by crossing mice containing a floxed tyrosine kinase domain of Ron (Ron F/F ) to mice expressing Cre recombinase under control of the lysozyme M promoter (Ron F/F Cre). 21 The LysMcre mice have been extensively utilized to generate efficient celltype specific deletion of loxP-flanked target genes at a 83-98% efficiency in macrophages and near 100% in granulocytes. 21 To examine the efficiency of the targeted ablation of the Ron TK domain in Ron F/F Cre mice, a competitive PCR strategy was devised to differentiate between wild type (WT), Ron F/F , and TK-deficient Ron as illustrated in Figure 1A . Utilizing DNA isolated from primary BAL cells from naı¨ve mice and primer sets to differentiate the Ron allele, we demonstrate that BAL cells from wild-type (TK +/+ ) mice yield the expected PCR band size of approximately 330 base pairs while TK deficient (TK À/À ) BAL cells isolated from germline TK-deficient mice yield the expected band size of approximately 390 base pairs. The PCR analyses with Ron F/F isolated BAL cells yield the expected band size of 360 base pairs representing the floxed Ron TK allele. The experimental Ron F/F Cre BAL cells exhibit a prominent band at 390 base pairs and a faint secondary band at 360 base pairs. These data suggest that the DNA isolated from Ron F/F Cre BAL cells contains predominately Ron TK-ablated cells. Of note, BAL cells isolated from naı¨ve Ron F/F Cre mice, as well as Ron F/F mice, consist primarily of monocytes/macrophages (92-95%), and suggest that Ron is efficiently ablated in this cell type.
Previously, we documented Ron receptor expression in both the lung epithelial cells and in primary murine alveolar macrophages at both the protein and transcript level. 15, 20 To examine Ron expression in the lungs of Ron F/F and Ron F/F Cre mice, Figure 1B demonstrates that the level of Ron transcript in whole lung lysates from Ron F/F Cre mice remains largely unchanged compared to Ron F/F controls. In contrast, however, Figure 1C indicates that the Ron transcript levels in Ron F/F Cre BAL cells are almost completely ablated compared to Ron F/F controls. 
Histology reveals increased pulmonary damage and immune cell infiltration in Ron F/F Cre mice following LPS challenge in vivo
We have previously demonstrated that a whole body deletion of the Ron receptor tyrosine kinase domain in mice resulted in increased susceptibility to lung damage following LPS exposure. 17 However, these experiments did not differentiate the cell type regulating Ron-dependent injury in vivo. In order to characterize the contribution of Ron in the immune compartment in LPS-induced acute lung injury mice, Ron F/F Cre mice were challenged with intranasal administration of LPS and compared to Ron F/F control mice. Figure 2 shows increased levels of inflammatory cell infiltration of the lung parenchyma in Ron F/F Cre compared to Ron F/F controls. Notably, Ron F/F Cre mice exhibit increased perivasculitis and acute lymphitis following LPS challenge compared to Ron F/F controls.
Increased levels of cellular inflammation in Ron F/F Cre mice
Given the increased inflammatory cells observed in the lungs of LPS-challenged Ron F/F Cre mice, we next quantitated the extent of cellular infiltration into the lungs of Ron F/F Cre and Ron F/F mice prior to and after LPS exposure. In Figure 3A , we show that LPS-challenged Ron F/F Cre mice displayed a marked increase in the cellular infiltrate into the BAL fluid compared to Ron F/F controls. Notably, a significant increase in neutrophil accumulation was observed in the Ron F/F Cre BAL fluid compared to Ron F/F controls (n ¼ 4; P < 0.05). We were next interested in determining if the increased neutrophil levels observed in the BAL fluid coincided with increased neutrophilia in the lungs. In Figure 3B , we quantitated the number of neutrophils present in the lungs of Ron F/F Cre and Ron F/F mice following challenge with LPS. Our results demonstrate increased numbers of neutrophils in the lungs of Ron F/F Cre mice compared to Ron F/F controls. In Figure 3C , we show representative images of neutrophil specific staining in the lungs of the Ron F/F Cre and Ron F/F mice by immunohistochemistry. Taken together, these results indicate significant increases in neutrophil accumulation into the lungs and BAL fluid of Ron F/F Cre mice compared to Ron F/F mice following LPS challenge.
Increased levels of TNF-in Ron F/F Cre mice
We next determined if the specific loss of the Ron receptor tyrosine kinase domain in myeloid cells would affect levels of the pro-inflammatory cytokine TNF-a in response to LPS challenge. To address TNF-a transcript levels, qRT-PCR was performed on whole lung cell lysates following challenge with LPS. In Figure 4A , we demonstrate a trend toward increased levels of TNF-a expression following LPS administration in Ron F/F Cre mice compared to Ron F/F control mice although these data were not statistically significant. Notably, in Figure 4B , we demonstrate increased levels of TNF-a in the BAL fluid of Ron F/F Cre mice compared to Ron F/F control mice following challenge with LPS. Together, these data are consistent with observed increases in neutrophil numbers, as well as our previous findings in whole body Ron receptor tyrosine kinase deficient mice.
Augmented NF-B phosphorylation in Ron F/F Cre mice with LPS challenge Previously, we demonstrated that whole lung homogenates from Ron-deficient mice treated with LPS exhibited augmented activation of the transcription factor NF-kB with associated decreased expression of IkBa and IkBb proteins. In addition, utilizing the murine macrophage cell line, MH-S cells, we have also demonstrated that Ron activation, by ligand stimulation, leads to reduced NF-kB reporter activity and NF-kB DNA binding activity in response to LPS stimulation compared to cells without ligand stimulation. 15 In order to determine if cell lineage specific targeted ablation of Ron receptor tyrosine kinase domain would be sufficient to recapitulate this phenotype in vivo, we examined the extent of phosphorylated NF-kB (pNF-kB) as a marker of NF-kB activation in saline-and LPS-treated lungs of Ron F/F Cre and Ron F/ F mice. In Figure 5 , we show increased levels of pNF-kB following challenge with LPS in Ron F/F Cre mice compared to Ron F/F mice. These data are consistent with our previous finding that complete loss of Ron receptor tyrosine kinase results in increased NF-kB activation and suggests that alveolar macrophages are a major contributor to this phenotype in vivo, although the role of neutrophils in this phenotype cannot be excluded.
Discussion
The LPS-induced mouse model of experimental acute lung injury is characterized by a pro-inflammatory cytokine cascade resulting in increased levels of pulmonary inflammation and tissue damage. 22 The immune signaling cascade, which results in this phenotype, is thought to be regulated, at least in part, through the initial activation of tissue resident macrophages. 1, 23 The negative regulation of the immune response following activation by LPS is thought to be mediated through a feedback inhibition loop. 24 We have previously demonstrated that complete loss of the Ron receptor tyrosine kinase domain results in increased lung damage and inflammatory cytokine production following acute lung injury induced by LPS in vivo compared to control mice. 17 Furthermore, we have also shown that primary murine alveolar macrophages and macrophage cell lines treated with the Ron ligand, HGFL, exhibit decreased cytokine production following LPS stimulation. 15 Together, these studies suggested that the Ron receptor tyrosine kinase may be an important contributor to the negative regulation of the innate immune response in vivo. This report examines the contribution of the immune compartment to Ron regulation of LPSinduced acute lung injury in vivo by using cell lineagespecific deletion of the Ron receptor tyrosine kinase domain. Our data reveal several principles associated with the regulation of acute lung injury in vivo. First, the Ron F/F Cre mice show diminished levels of Ron receptor expression in whole lung homogenates as measured by qRT-PCR. This finding is consistent with the ablation of the Ron receptor tyrosine kinase in BAL cells from naı¨ve mice as measured by qRT-PCR. Second, the targeted ablation of Ron receptor tyrosine kinase from myeloid cells results in increased lung damage and pulmonary inflammation. Specifically, we demonstrate increased levels of perivasculitis and acute lymphitis following LPS challenge compared to Ron F/F controls. These findings are consistent with the phenotype previously observed with whole body Ron knockouts. 15, 17 Third, we have identified that the increases in inflammatory cells following LPS challenge are comprised mainly of neutrophils. A significant increase in neutrophils in the Ron F/F Cre lungs was demonstrated in cells isolated from the broncho-alveolar lavage fluid by differential cell analyses and in the whole lungs as demonstrated by neutrophil-specific staining of fixed unlavaged tissue from LPS treated mice. These data indicate that increased neutrophilia following challenge with LPS may be the primary dysregulated phenotype following ablation of the Ron receptor tyrosine kinase domain from tissue resident macrophages. Finally, our data demonstrate that the targeted ablation of Ron receptor tyrosine kinase receptor from the immune compartment results in increased levels of TNF-a production as measured by transcript analysis by qRT-PCR as well as by protein analysis of BAL fluid following challenge with LPS. Additionally, we show increased levels of pNF-kB in the Ron F/F Cre mice compared to Ron F/F control mice, a finding which is consistent with increased NF-kB activation previously demonstrated both in vivo and in vitro. 15, 17 The use of mice with a conditional deletion of Ron in the immune compartment has furthered our previous findings such that the early regulation of acute lung injury in vivo by Ron is mediated primarily through the immune compartment of the lung.
It is important to note that this study did not address the role of the Ron receptor tyrosine kinase in the airway epithelium. Given the high level of expression of Ron in the airway epithelium, it would be interesting to determine what role, if any, the Ron receptor might have in recovery and wound healing following inflammatory damage. Given the known role of Ron signaling in epithelial migration and cellular proliferation, it is tempting to speculate that the Ron receptor signaling may play a protective role in the airway epithelium as well as the reported significant role in alveolar macrophages. Further studies are needed to elucidate the mechanisms by which the various cellular compartments in the lung contribute to the pathophysiology of acute lung injury in vivo and the mechanisms by which the Ron receptor may be used as a clinical tool to modulate and monitor injury.
